PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma

Carolyn L. Waite, Charles M. Roth

Research output: Contribution to journalArticlepeer-review

121 Scopus citations

Abstract

Generation 5 poly(amidoamine) (PAMAM) dendrimers were modified by the addition of cyclic RGD targeting peptides and were evaluated for their ability to associate with siRNA and mediate siRNA delivery to U87 malignant glioma cells. PAMAM-RGD conjugates were able to complex with siRNA to form complexes of approximately 200 nm in size. Modest siRNA delivery was observed in U87 cells using either PAMAM or PAMAM-RGD conjugates. PAMAM-RGD conjugates prevented the adhesion of U87 cells to fibrinogen-coated plates, in a manner that depends on the number of RGD ligands per dendrimer. The delivery of siRNA through three-dimensional multicellular spheroids of U87 cells was enhanced using PAMAM-RGD conjugates compared to the native PAMAM dendrimers, presumably by interfering with integrin-ECM contacts present in a three-dimensional tumor model.

Original languageEnglish (US)
Pages (from-to)1908-1916
Number of pages9
JournalBioconjugate Chemistry
Volume20
Issue number10
DOIs
StatePublished - Oct 21 2009

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma'. Together they form a unique fingerprint.

Cite this